PepLib
Biotechnology Research • 
Hetang District, Hunan, China • 1-10 Employees
Company overview
| Headquarters | Building 5, 1769 Yunlong Blvd., Shifeng District, Zhuzhou, Hunan 412000, CN |
| Phone number | +8673122188995 |
| Website | |
| NAICS | 541714 |
| Keywords | RDC, PDC, Peptide Drug Discovery, Gpcr Targets, Peptide Hit, Peptide Lead |
| Founded | 2017 |
| Employees | 1-10 |
| Socials |
Key Contact at PepLib
Weiliang Timo
Associate Director of Business Development
About PepLib
Zonsen PepLib Biotech Inc. is a high-tech biopharmaceutical enterprise that is dedicated to advancing global innovation in the discovery of new peptide drugs. Founded in September 2017, PepLib is headquartered in Zhuzhou, China, with a subsidiary in New Jersey, USA. Our core peptide discovery platform is called Peptide Information Compression Technology (PICT), which consists of a diverse peptide library named ZSenithFive®, containing information on nearly half-billion peptides. The PICT platform is ideal for the discovery of functionally active peptides directly from cell-based and biochemical high-throughput screening (HTS) assays. In addition, we have developed 4 complimentary peptide discovery platforms: the Disulfide-rich Peptide Phage Display (DRP-PD) platform, the Animal Toxin Peptide Library Platform, the Nano-Cyclic Peptide Library Platform, and the Virtual Peptide Library Platform. PepLib successfully raised 100 million yuan (USD 16 million) in Series Pre-A financing in 2019 and secured Series A financing of 220 million yuan (USD 35 million) in 2021. PepLib has been working towards Series Pre-IPO financing since March 2022. PepLib has more than 190 employees, and more than 80% of the workforce is made up of R&D personnel. At PepLib, our main therapeutic area focus is oncology and cardiometabolic diseases, where oncology programs are driven by the development of peptide drug conjugates (PDCs) and peptide radionuclide conjugates (PRCs).
PepLib revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | $48,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Explore PepLib's funding history, including investment rounds, total capital raised, and key backers.
Czechia
United Kingdom
Frequently asked questions
4.8
40,000 users
